Biblio

2024
Wilkinson AC. Take the MYC to expand blood stem cells. Blood. 2024;143(10):838-840.
Seclen E, Jang JC, Lawal AO, Pulicani S, Boyne A, Tkach D, Juillerat A, Duchateau P, Valton J. TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage. Mol Ther. 2024.
Barajas JM, Umeda M, Contreras L, Khanlari M, Westover T, Walsh MP, Xiong E, Yang C, Otero B, Arribas-Layton M, et al. tandem duplications in pediatric myelodysplastic syndrome and acute myeloid leukemia: implications for clinical screening and diagnosis. Haematologica. 2024.
Hoang C, Uritboonthai W, Hoang L, Billings EM, Aisporna A, Nia FA, Derks RJE, Williamson JR, Giera M, Siuzdak G. Tandem Mass Spectrometry across Platforms. Anal Chem. 2024.
Jiang X, Zhu W, Sun Y, Wang S, Sun M, Tang R, Tang Z, Ma T. Tandem mass tag-based quantitative proteomics analyses of the spermatogenesis-ameliorating effect of Youjing granule on rats. Rapid Commun Mass Spectrom. 2024;38(3):e9679.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, et al. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring. Nat Commun. 2024;15(1):3302.
Zhao L-L, Luo J-J, Cui J, Li X, Hu R-N, Xie X-Y, Zhang Y-J, Ding W, Ning L-J, Luo J-C, et al. Tannic Acid-Modified Decellularized Tendon Scaffold with Antioxidant and Anti-Inflammatory Activities for Tendon Regeneration. ACS Appl Mater Interfaces. 2024.
Guo R, Liu H, Su R, Mao Q, Zhao M, Zhang H, Mu J, Zhao N, Wang Y, Hao Y. Tanreqing injection inhibits influenza virus replication by promoting the fusion of autophagosomes with lysosomes: An integrated pharmacological study. J Ethnopharmacol. 2024:118159.
Yang J, Gong X, Li T, Xia Z, He R, Song X, Wang X, Wu J, Chen J, Wang F, et al. Tantalum Particles Promote M2 Macrophage Polarization and Regulate Local Bone Metabolism via Macrophage-Derived Exosomes Influencing the Fates of BMSCs. Adv Healthc Mater. 2024:e2303814.
Wang Q, Zhang R, He Y, Mao G, Kong Z. Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway. Int J Radiat Biol. 2024:1-11.
Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024.
Fatima N, Umar M, Ambreen S, Shaququzzaman M, Alam MMumtaz, Ali R. Targeted Cancer Stem Cell Therapeutics: An Update. Curr Top Med Chem. 2024.
Ke F, Benet ZL, Shelyakin P, Britanova OV, Gupta N, Dent AL, Moore BB, Grigorova IL. Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells. Proc Natl Acad Sci U S A. 2024;121(5):e2304020121.
Karbassi E, Padgett R, Bertero A, Reinecke H, Klaiman JM, Yang X, Hauschka SD, Murry CE. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cell Mol Life Sci. 2024;81(1):95.
Jiang Y, Yu M, Song Z-F, Wei Z-Y, Huang J, Qian H-Y. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomedicine. 2024;19:2553-2571.
Zhang Z, Zhang S, Wong HTing, Li D, Feng B. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight. BioDrugs. 2024.
Glaser KM, Egg M, Hobitz S, Mitterer M, Schain-Zota D, Schönberger K, Schuldes K, Cabezas-Wallscheid N, Lämmermann T, Rambold A, et al. Targeted Metabolomics on Rare Primary Cells. J Vis Exp. 2024;(204).
de Vries ISNaarmann, Dieterich C. Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination. Methods Mol Biol. 2024;2765:127-142.
Eichholz T, Heubach F, Arendt A-M, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunol Immunother. 2024;73(1):19.
Yang Q, Gao W, Li X, Li X, Zhou X, Li W, Zhou C, Luo A, Liu Z. Targeting ABCA1 via Extracellular vesicle-Encapsulated Staurosporine as a Therapeutic Strategy to enhance Radiosensitivity. Adv Healthc Mater. 2024:e2400381.
Chen X, Sun X, Ge Y, Zhou X, Chen J-F. Targeting adenosine A receptors for early intervention of retinopathy of prematurity. Purinergic Signal. 2024.
Huang T, Lu Z, Wang Z, Cheng L, Gao L, Gao J, Zhang N, Geng C-A, Zhao X, Wang H, et al. Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow. Nat Commun. 2024;15(1):3769.
Du J, Wang Y, Wu C, Zhang X, Zhang X, Xu X. Targeting bone homeostasis regulation: potential of traditional Chinese medicine flavonoids in the treatment of osteoporosis. Front Pharmacol. 2024;15:1361864.
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, Singh G, Sharma A, Rao N, Kaushik D. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier. Oncol Res. 2024;32(5):877-897.
Alcala S, Villarino L, Ruiz-Cañas L, Couceiro JR, Martínez-Calvo M, Palencia-Campos A, Navarro D, Cabezas-Sainz P, Rodriguez-Arabaolaza I, Cordero-Barreal A, et al. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy. J Exp Clin Cancer Res. 2024;43(1):33.

Pages